286 related articles for article (PubMed ID: 25834103)
1. Lipin-1 regulates cancer cell phenotype and is a potential target to potentiate rapamycin treatment.
Brohée L; Demine S; Willems J; Arnould T; Colige AC; Deroanne CF
Oncotarget; 2015 May; 6(13):11264-80. PubMed ID: 25834103
[TBL] [Abstract][Full Text] [Related]
2. Effects of the mammalian target of rapamycin inhibitor CCI-779 used alone or with chemotherapy on human prostate cancer cells and xenografts.
Wu L; Birle DC; Tannock IF
Cancer Res; 2005 Apr; 65(7):2825-31. PubMed ID: 15805283
[TBL] [Abstract][Full Text] [Related]
3. Geraniol induces cooperative interaction of apoptosis and autophagy to elicit cell death in PC-3 prostate cancer cells.
Kim SH; Park EJ; Lee CR; Chun JN; Cho NH; Kim IG; Lee S; Kim TW; Park HH; So I; Jeon JH
Int J Oncol; 2012 May; 40(5):1683-90. PubMed ID: 22200837
[TBL] [Abstract][Full Text] [Related]
4. Dual inhibition by S6K1 and Elf4E is essential for controlling cellular growth and invasion in bladder cancer.
Kyou Kwon J; Kim SJ; Hoon Kim J; Mee Lee K; Ho Chang I
Urol Oncol; 2014 Jan; 32(1):51.e27-35. PubMed ID: 24239466
[TBL] [Abstract][Full Text] [Related]
5. The antitumor effect of GDC-0941 alone and in combination with rapamycin in breast cancer cells.
Zheng J; Zou X; Yao J
Chemotherapy; 2012; 58(4):273-81. PubMed ID: 23006739
[TBL] [Abstract][Full Text] [Related]
6. Combined treatment with cisplatin and sirolimus to enhance cell death in human mesothelioma.
Hartman ML; Esposito JM; Yeap BY; Sugarbaker DJ
J Thorac Cardiovasc Surg; 2010 May; 139(5):1233-40. PubMed ID: 19853261
[TBL] [Abstract][Full Text] [Related]
7. Lipin-1 regulation of phospholipid synthesis maintains endoplasmic reticulum homeostasis and is critical for triple-negative breast cancer cell survival.
He J; Zhang F; Tay LWR; Boroda S; Nian W; Levental KR; Levental I; Harris TE; Chang JT; Du G
FASEB J; 2017 Jul; 31(7):2893-2904. PubMed ID: 28347999
[TBL] [Abstract][Full Text] [Related]
8. Rapamycin inhibits proliferation of estrogen-receptor-positive breast cancer cells.
Chang SB; Miron P; Miron A; Iglehart JD
J Surg Res; 2007 Mar; 138(1):37-44. PubMed ID: 17109887
[TBL] [Abstract][Full Text] [Related]
9. Dual function lipin proteins and glycerolipid metabolism.
Harris TE; Finck BN
Trends Endocrinol Metab; 2011 Jun; 22(6):226-33. PubMed ID: 21470873
[TBL] [Abstract][Full Text] [Related]
10. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
[TBL] [Abstract][Full Text] [Related]
11. Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.
Liu H; Scholz C; Zang C; Schefe JH; Habbel P; Regierer AC; Schulz CO; Possinger K; Eucker J
Anticancer Res; 2012 May; 32(5):1627-37. PubMed ID: 22593441
[TBL] [Abstract][Full Text] [Related]
12. Insulin-stimulated phosphorylation of lipin mediated by the mammalian target of rapamycin.
Huffman TA; Mothe-Satney I; Lawrence JC
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):1047-52. PubMed ID: 11792863
[TBL] [Abstract][Full Text] [Related]
13. The phosphatidic acid-binding, polybasic domain is responsible for the differences in the phosphoregulation of lipins 1 and 3.
Boroda S; Takkellapati S; Lawrence RT; Entwisle SW; Pearson JM; Granade ME; Mullins GR; Eaton JM; Villén J; Harris TE
J Biol Chem; 2017 Dec; 292(50):20481-20493. PubMed ID: 28982975
[TBL] [Abstract][Full Text] [Related]
14. Embelin inhibits growth and induces apoptosis through the suppression of Akt/mTOR/S6K1 signaling cascades.
Kim SW; Kim SM; Bae H; Nam D; Lee JH; Lee SG; Shim BS; Kim SH; Ahn KS; Choi SH; Sethi G; Ahn KS
Prostate; 2013 Feb; 73(3):296-305. PubMed ID: 22887478
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.
deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M
Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.
Marzec M; Kasprzycka M; Liu X; El-Salem M; Halasa K; Raghunath PN; Bucki R; Wlodarski P; Wasik MA
Oncogene; 2007 Aug; 26(38):5606-14. PubMed ID: 17353907
[TBL] [Abstract][Full Text] [Related]
17. Proto-oncogene Src links lipogenesis via lipin-1 to breast cancer malignancy.
Song L; Liu Z; Hu HH; Yang Y; Li TY; Lin ZZ; Ye J; Chen J; Huang X; Liu DT; Zhou J; Shi Y; Zhao H; Xie C; Chen L; Song E; Lin SY; Lin SC
Nat Commun; 2020 Nov; 11(1):5842. PubMed ID: 33203880
[TBL] [Abstract][Full Text] [Related]
18. Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers.
Zhou X; Tan M; Stone Hawthorne V; Klos KS; Lan KH; Yang Y; Yang W; Smith TL; Shi D; Yu D
Clin Cancer Res; 2004 Oct; 10(20):6779-88. PubMed ID: 15501954
[TBL] [Abstract][Full Text] [Related]
19. Identification of lipidomic profiles associated with drug-resistant prostate cancer cells.
Ingram LM; Finnerty MC; Mansoura M; Chou CW; Cummings BS
Lipids Health Dis; 2021 Feb; 20(1):15. PubMed ID: 33596934
[TBL] [Abstract][Full Text] [Related]
20. A novel semisynthetic inhibitor of the FRB domain of mammalian target of rapamycin blocks proliferation and triggers apoptosis in chemoresistant prostate cancer cells.
Morad SA; Schmid M; Büchele B; Siehl HU; El Gafaary M; Lunov O; Syrovets T; Simmet T
Mol Pharmacol; 2013 Feb; 83(2):531-41. PubMed ID: 23208958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
